Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03546491 · ClinicalTrials.gov registry record · Phase 3
Evaluate Dental Plaque Benefit of a Preventive Treatment Gel
A Phase 3 study, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 3
- Development phase
- 32
- Enrollment target
NCT03546491 is a Phase 3 study that has completed, run by Procter and Gamble. The registered enrollment target is 32 participants.
The verdict
NCT03546491, a Phase 3 study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 32 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate anti-plaque efficacy of a preventive treatment gel in a modified 4-day plaque model.
Interventions
- DRUG Preventive Gel
- DRUG Marketed Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-05-08 |
| Est. Completion | 2018-06-22 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03546491
The ClinicalTrials.gov registry entry for NCT03546491 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Preventive Gel is the first listed.
NCT03546491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03546491 about?
NCT03546491 is a clinical study titled "Evaluate Dental Plaque Benefit of a Preventive Treatment Gel". The objective of the study is to evaluate anti-plaque efficacy of a preventive treatment gel in a modified 4-day plaque model.
What is the current status of trial NCT03546491?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 32 participants. The study started on 2018-05-08. Estimated completion is 2018-06-22.
What interventions are being tested in trial NCT03546491?
The interventions under investigation include: Preventive Gel (DRUG), Marketed Control (DRUG).
Who is sponsoring clinical trial NCT03546491?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.